As you read here in February, David Tuller and I attempted to respond to an alarming research paper that appeared in a recent issue of the Journal of the Royal Society of Medicine. The paper they had published had purported to show evidence that cognitive behavioural therapy leads to symptom improvements in […]
Swiss Re Group, “one of the world’s leading providers of reinsurance and insurance,” recently hosted a virtual Expert Forum on “secondary” impacts of COVID. As would be expected, the insurance industry is especially interested in the financial implications of this new disease. The programme covered many of the biophysical sequelae […]
Here is a video of a lecture I gave in Belfast just before COVID, entitled “Off the PACE and not NICE: Challenges with Evidence in ME/CFS.” The lecture was part of a conference organised by Hope 4 ME & Fibro NI (kudos to Joan McParland and team). It hasn’t been […]
David Tuller, Vincent Racaniello, and I have written to the BMJ about that guest editorial on the draft NICE guidelines for ME and related conditions. The letter is also online over at Virology Blog and has now been posted as a Rapid Response on BMJ.com. * * * Subject line: […]
An invited, non-peer-reviewed guest editorial in the BMJ has claimed that behavioural interventions for “complex conditions” (such as ME or CFS) should not be judged using the customary criteria — and that the relevant studies should not be evaluated as though they were proper randomised controlled trials — because, among […]
The newly released draft NICE guidelines for the management of “myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome” continue to cause a stir. And rightly so. The new guidelines not only repudiate a heretofore favoured treatment approach for a particular illness, they also threaten to discredit an entire (albeit quirky) branch of […]
